Poland· PL-100209777
Flumazenil Pharmaselect 0,1 mg/ml
A flumazenil product containing flumazenilum, registered in Poland by Pharmaselect International Beteiligungs GmbH. The same ATC class is registered in 17 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Flumazenil is registered in 17 of 19 countries.
Countries holding a registration under ATC V03AB25 (flumazenil), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Flumazenil · ATC V03AB25
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Flumazenilum
- Manufacturer
- Pharmaselect International Beteiligungs GmbH
- Country
- Poland (PL)
- ATC code
- V03AB25
- ATC class
- Flumazenil
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 4
- gtin05909990701612
- gtin05909990701629
- gtin05909990701636
- gtin05909990701643
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
63 interactions on record for flumazenil.
Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Flumazenil · interactions on record
63 records
- 11 severe
- 16 moderate
- 3 minor
- 33 info
Most severe, free to view
- DoxepinD04AX01severe
- DesipramineN06AA01severe
- ImipramineN06AA02severe
- ClomipramineN06AA04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Flumazenil in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaFLUMAZENIL PHARMASELECTPharmaselect International Beteiligungs GmbH, Vídeň
- United StatesFlumazenilMedical Purchasing Solutions, LLC
- United KingdomAnexate 500micrograms/5ml solution for injection ampoulesRoche Products Ltd
- GermanyAnexateCheplapharm Arzneimittel Gmbh
- SpainANEXATE 0,5 mg/5 ml SOLUCION INYECTABLECheplapharm Arzneimittel Gmbh
- FinlandFlumazenil ActavisActavis Group PTC ehf
- SwitzerlandAnexate, InjektionslösungCheplapharm Schweiz GmbH
- NetherlandsAnexate, 0,5 mg/5 ml en 1,0 mg/ 10 ml oplossing voor injectieCHEPLAPHARM Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Anexate, Flumazenil B. Braun
- Belgium · Anexate, Flumazenil B. Braun
- Czechia · Flumazenil Pharmaselect
- Germany · Anexate, Flumazenil B. Braun
- Denmark · Flumazenil Fresenius Kabi, Flumazenil Hameln
- Spain · Anexate, Flumazenil Altan
- Finland · Flumazenil B. Braun, Flumazenil Fresenius Kabi
- France · Flumazenil Hikma, Flumazenil Viatris
- United Kingdom (Northern Ireland) · Flumazenil Hameln Pharma, Flumazenil Hikma Farmacêutica (Portugal)
- Greece · Anexate®, Demoxate
- Croatia · Anexate, Flumazenil B.Braun
- Hungary · Anexate, Flumazenil Kabi
- Ireland · Anexate
- Iceland · Flumazenil B. Braun
- Italy · Anexate, Flumazenil B. Braun
- Luxembourg · Flumazenil B. Braun
- Netherlands · Anexate, Flumazenil B. Braun
- Norway · Flumazenil Fresenius Kabi, Flumazenil Hameln
- Portugal · Flumazenilo Fresenius Kabi, Flumazenilo Generis
- Romania · Anexate, Flumazenil Pharmaselect
- Sweden · Flumazenil Fresenius Kabi, Flumazenil Hameln
- Slovenia · Anexate
- Slovakia · Flumazenil Pharmaselect
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d8a58b64-4776-49f5-b5d4-49fc483fd9b0 GET /v1/drugs/d8a58b64-4776-49f5-b5d4-49fc483fd9b0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań lub koncentrat do sporządzania roztworu do infuzji",
"source": "urpl",
"strength": "0,1 mg/ml",
"packaging": "05909990701612 ¦ Rp ¦ 50387\n5 amp. 5 ml\n05909990701629 ¦ Rp ¦ 50388\n5 amp. 10 ml\n05909990701636 ¦ Rp ¦ 50389\n10 amp. 5 ml\n05909990701643 ¦ Rp ¦ 50390\n10 amp. 10 ml",
"substance": "Flumazenilum 0.1 mg/ml",
"common_name": "Flumazenilum",
"pl_product_id": "100209777",
"pozwolenie_nr": "15532",
"auth_procedure": "DCP",
"authorisation_validity": "Bezterminowe"
}See everything about flumazenil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.